287 related articles for article (PubMed ID: 27983717)
1. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer.
Mitchell SM; Ho T; Brown GS; Baker RT; Thomas ML; McEvoy A; Xu ZZ; Ross JP; Lockett TJ; Young GP; LaPointe LC; Pedersen SK; Molloy PL
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27983717
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
Young GP; Symonds EL; Nielsen HJ; Ferm L; Christensen IJ; Dekker E; van der Vlugt M; Mallant-Hent RC; Boulter N; Yu B; Chan M; Tevz G; LaPointe LC; Pedersen SK
Clin Epigenetics; 2021 Jan; 13(1):14. PubMed ID: 33478584
[TBL] [Abstract][Full Text] [Related]
3.
Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
[TBL] [Abstract][Full Text] [Related]
5. A panel of genes methylated with high frequency in colorectal cancer.
Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
[TBL] [Abstract][Full Text] [Related]
6. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
Winter JM; Sheehan-Hennessy L; Yao B; Pedersen SK; Wassie MM; Eaton M; Chong M; Young GP; Symonds EL
Cancer Biomark; 2022; 34(3):493-503. PubMed ID: 35253733
[TBL] [Abstract][Full Text] [Related]
7. A two-gene blood test for methylated DNA sensitive for colorectal cancer.
Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC
PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810
[TBL] [Abstract][Full Text] [Related]
8. Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1.
Symonds EL; Pedersen SK; Yeo B; Al Naji H; Byrne SE; Roy A; Young GP
Mol Oncol; 2022 May; 16(10):2031-2041. PubMed ID: 35000264
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
[TBL] [Abstract][Full Text] [Related]
11. Variables Associated with Detection of Methylated
Saluja H; Young GP; Kholmurodova F; Symonds EL
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):774-781. PubMed ID: 33500319
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer.
Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948
[TBL] [Abstract][Full Text] [Related]
13. Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
Pedersen SK; Symonds EL; Roy AC; Cornthwaite KJ; LaPointe LC; Young GP
Cancer Med; 2023 Jan; 12(2):1319-1329. PubMed ID: 35822405
[TBL] [Abstract][Full Text] [Related]
14. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of Colorectal Cancer.
Petit J; Carroll G; Williams H; Pockney P; Scott RJ
Med Sci (Basel); 2023 Sep; 11(3):. PubMed ID: 37755164
[TBL] [Abstract][Full Text] [Related]
16. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.
Murray DH; Symonds EL; Young GP; Byrne S; Rabbitt P; Roy A; Cornthwaite K; Karapetis CS; Pedersen SK
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1741-1750. PubMed ID: 29992492
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA.
Lyskjær I; Kara N; De Noon S; Davies C; Rocha AM; Strobl AC; Usher I; Gerrand C; Strauss SJ; Schrimpf D; von Deimling A; Beck S; Flanagan AM
Eur J Cancer; 2022 Jun; 168():1-11. PubMed ID: 35421838
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
Terp SK; Stoico MP; Dybkær K; Pedersen IS
Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
[TBL] [Abstract][Full Text] [Related]
20. Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.
Symonds EL; Pedersen SK; Murray D; Byrne SE; Roy A; Karapetis C; Hollington P; Rabbitt P; Jones FS; LaPointe L; Segelov E; Young GP
Cancer; 2020 Apr; 126(7):1460-1469. PubMed ID: 31909823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]